Morgan Stanley reaffirmed their equal weight rating on shares of Demant A/S (OTCMKTS:WILLF) in a research report report published on Tuesday morning, The Fly reports.
Several other equities research analysts have also recently weighed in on the company. Exane BNP Paribas cut Demant A/S from a neutral rating to an underperform rating in a report on Wednesday, May 12th. Redburn Partners raised shares of Demant A/S from a sell rating to a neutral rating in a research report on Friday, February 19th. SEB Equities upgraded shares of Demant A/S from a hold rating to a buy rating in a research note on Wednesday, February 10th. Finally, Credit Suisse Group upgraded Demant A/S from an underperform rating to a neutral rating in a report on Friday, April 16th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the stock. Demant A/S currently has an average rating of Hold.
Shares of WILLF opened at $54.55 on Tuesday. Demant A/S has a 1-year low of $28.40 and a 1-year high of $54.55. The firm’s 50-day moving average is $49.43.
Demant A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. It operates through two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment offers hearing implants and aids, hearing care, and diagnostic products.
Featured Story: Learning About the VIX – Volatility Index
Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.